ライフサイエンスコーパス: low birth weight infant

1 risk of chronic lung disease (ie, extremely low birth weight infants).

2 guidelines for the approach to the extremely low birth weight infant.

3 on in the premature and especially extremely low birth weight infant.

4 d moderate anemia, and 1 delivered a preterm low-birth-weight infant.

5 a major cause of morbidity and mortality in low birth weight infants.

6 ther morbid conditions in full-term and very low birth weight infants.

7 ctor for intraventricular hemorrhage in very low birth weight infants.

8 tein intake may improve growth in these very low birth weight infants.

9 aggressive administration of protein to very low birth weight infants.

10 ive care units, particularly among extremely low birth weight infants.

11 declined for low birth weight and extremely low birth weight infants.

12 lsy in a geographically based cohort of very low birth weight infants.

13 e clinical risk and illness severity in very low birth-weight infants.

14 use of prophylactic fluconazole in extremely low-birth-weight infants.

15 f chronic lung disease or death in extremely low-birth-weight infants.

16 facilities might reduce mortality among very-low-birth-weight infants.

17 better access to improved neonatal care for low-birth-weight infants.

18 levels of care and different volumes of very-low-birth-weight infants.

19 ns, and thus should not be used in extremely-low-birth-weight infants.

20 candidiasis and/or colonization of extremely-low-birth-weight infants.

21 e-negative staphylococcal infections in very-low-birth-weight infants.

22 nization and invasive infection in extremely-low-birth-weight infants.

23 on but potentially lethal problem among very-low-birth-weight infants.

24 of low-birth-weight and 4.3 percent of very-low-birth-weight infants.

25 n sparing protein oxidation in enterally fed low-birth-weight infants.

26 he risk of chronic lung disease in extremely-low-birth-weight infants.

27 chronic lung disease and sepsis in extremely-low-birth-weight infants.

28 during pregnancy can lead to the delivery of low-birth-weight infants.

29 ght infants (<2500 g), of whom 336 were term low-birth-weight infants (1501-2499 g and gestation > or

30 The results suggest that, for ultra-low birth weight infants (23-25 wk gestational age), the

31 , 0.90; 95% CI, 0.66 to 1.25), delivery of a low-birth-weight infant (4.1% and 3.7%; prevalence odds

32 eeks of age in 371 ventilator-dependent very-low-birth-weight infants (501 to 1500 g) who had respira

33 The majority of very low birth weight infants (52%) were discharged on formul

34 Other than in low birth weight infants, adverse effects were rare and

35 Diminution in risk was greater for very low birth weight infants, amounting to a sevenfold reduc

36 iated with not breastfeeding was greater for low birth weight infants and infants whose mothers had l

37 ase, pulmonary disease, pre-term delivery of low birth weight infants and metabolic disease.

38 A total of 207 cases were preterm or low-birth-weight infants and 534 were non-low-birth-weig

39 g gestation occurred in 21 (1.9%) mothers of low-birth-weight infants and, when compared with women w

40 health with cardiovascular disease, preterm low birth weight infants, and early death from any cause

41 r disease, necrotizing enterocolitis in very low birth weight infants, and hepatic encephalopathy.

42 ity (all causes), and infant mortality; more low-birth-weight infants; and higher levels on all 9 spe

43 Very low birth weight infants are at high risk, particularly

44 Low birth weight infants are at increased risk of cerebr

45 n volumes were markedly reduced in extremely low birth weight infants as compared to term newborns (r

46 asia (BPD) is a chronic lung disease of very low birth weight infants, associated with oxygen therapy

47 uble-blind randomized clinical trial in very low-birth-weight infants (birth weight <1500 g) admitted

48 ays of life and compared them with 7606 very-low-birth-weight infants born at centers in the network

49 ompared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979 (mea

50 Low-birth-weight infants, born after a preterm birth or

51 Brain growth measurements in extremely low birth weight infants can advance our understanding o

52 k of bronchopulmonary dysplasia in extremely-low-birth-weight infants, clinicians attempt to minimize

53 The neonatal mortality rate among all very-low-birth-weight infants decreased 17 percent, from 220.

54 g black infants, the mortality rate for very-low-birth-weight infants did not change significantly (1

55 support by nurses have higher rates of very low birth weight infants discharged home on human milk.

56 between the dependent variable (rate of very low birth weight infants discharged on "any human milk")

57 odevelopmental impairment (NDI) in extremely low birth weight infants (ELBW; <1000 g).

58 ure of dermal structure and function in very low birth weight infants, evidence of mechanical fragili

59 Most conventionally managed very low birth weight infants experience postnatal growth res

60 Among a large population of low-birth-weight infants, eyes with normal grating acuit

61 We tested the hypothesis that low-birth-weight infants fed a diet containing 65% of no

62 magnified in the resuscitation of extremely low birth weight infants for whom maintenance of a neutr

63 s been used in the nutritional management of low-birth-weight infants for the past 25 years.

64 Iron drops are recommended for low-birth-weight infants; for breast-fed infants with bi

65 ring within 72 hours after birth) among very-low-birth-weight infants have changed in recent years, s

66 Very-low-birth-weight infants have high levels of duodenal co

67 ible after birth at 2.5-3.0 g/kg/day in very low birth weight infants; however, there are no long-ter

68 rtionate number of low-birth-weight and very-low-birth-weight infants in the United States, in part b

69 per immunization schedules for premature and low-birth-weight infants in the United States.

70 The percentage of low-birth-weight infants increased from 51.0% to 54.0%.

71 Very low-birth-weight infant infection rates were 16.4% in 20

72 Major surgery in very low-birth-weight infants is independently associated wit

73 pulation, but levels of vaccination for very low-birth-weight infants lag slightly behind.

74 births in Washington State; 1,117 women with low-birth-weight infants (< 2,500 g) were compared with

75 0-3999 g), while the admission rate for very low-birth-weight infants (<1500 g) was 844.1 per 1000 li

76 Cases were 1117 women with low-birth-weight infants (<2500 g), of whom 336 were ter

77 high level of care and a high volume of very-low-birth-weight infants (more than 100 per year), lower

78 Controlling for low birth weight, infant mortality, average income (soci

79 regnancy were not at an increased risk for a low-birth-weight infant (odds ratio = 0.75, 95% confiden

80 iated with an adjusted odds ratio (OR) for a low-birth-weight infant of 2.27 (95% confidence interval

81 as associated with an adjusted OR for a term low-birth-weight infant of 3.61 (95% CI, 1.46-8.92, P =.

82 ght to determine whether mothers who deliver low birth weight infants or who suffer related pregnancy

83 he past 2 decades on the development of very-low-birth-weight infants' oral feeding skills.

84 dence of effect modification by inclusion of low birth weight infants (p=0.367) and no difference in

85 tive use of preventive therapies in the very low birth weight infant population.

86 account for an increasing percentage of all low-birth-weight infants, preterm births, and infant mor

87 GC) therapy, while approximately 19% of very low birth weight infants receive postnatal GC therapy.

88 k of necrotizing enterocolitis (NEC) in very low birth weight infants receiving indomethacin (INDO) t

89 yielded similar short-term outcomes in very low-birth-weight infants regarding safety and efficacy w

90 did not improve outcomes in premature, very low-birth-weight infants requiring a transfusion.

91 y provided reference range for uNGAL in very low birth weight infants shows that normative values for

92 o be associated with a preterm delivery of a low birth weight infant than mother's age, race, number

93 hazard dumpsites had a higher proportion of low birth weight infants than did infants from mothers i

94 Chinese women were less likely to have very low birth weight infants than were whites.

95 Among extremely-low-birth-weight infants, the rate of survival to 36 wee

96 We studied 5447 very-low-birth-weight infants (those weighing between 401 and

97 Very-low-birth-weight infants (those weighing less than 1500

98 Mortality rates among very-low-birth-weight infants varied according to both the vo

99 In addition, delivery of low birth weight infants was not associated with levels

100 C. albicans by lymphocytes from preterm and low-birth weight infants was significantly reduced, comp

101 Mortality among very-low-birth-weight infants was lowest for deliveries that

102 Sixty-two low-birth-weight infants weighing from 750 to 1600 g at

103 A consecutive cohort of extremely low birth weight infants who survived to 38 weeks postme

104 s neonatal mortality rates among 48,237 very-low-birth-weight infants who were born in California hos

105 assionate use of tin mesoporphyrin in a very low birth weight infant with intrauterine growth retarda

106 re (1) using balloon angioplasty to palliate low birth weight infants with critical coarctation, (2)

107 s regarding the best method of managing very low birth weight infants with PDA and whether to employ

108 ntion of IC has become a major focus in very low birth weight infants, with fluconazole increasingly

109 n in terms of the pulmonary outcome for very-low-birth-weight infants without an increase in the occu